Education program to help manage chronic rheumatic heart disease
Effectiveness of Chronic Self-management Education on Behavioral and Clinical Outcomes of Patients With Rheumatic Heart Disease at Jimma Medical Center (JMC): A Pseudo Quasi Experimental Design
NA · Jimma University · NCT06400628
This study is testing an education program to help people with chronic rheumatic heart disease manage their condition better and reduce feelings of anxiety and depression.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 166 (estimated) |
| Ages | 15 Years and up |
| Sex | All |
| Sponsor | Jimma University (other) |
| Locations | 1 site (Jimma, Oromi) |
| Trial ID | NCT06400628 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of a chronic disease self-management education program aimed at improving clinical outcomes and reducing anxiety and depression among patients with rheumatic heart disease. Conducted at Jimma Medical Center, the program involves monthly educational sessions over four months, with assessments of clinical and laboratory measurements before and after the intervention. Participants will undergo blood tests and complete the Hospital Anxiety and Depression Scale to measure their mental health status. The study aims to provide a structured approach to managing their condition through education and support.
Who should consider this trial
Good fit: Ideal candidates are patients aged 15 and older with a confirmed diagnosis of rheumatic heart disease for at least six months.
Not a fit: Patients with serious medical conditions or chronic illnesses such as COPD, diabetes, or advanced-stage cancer may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve the quality of life and mental health of patients with rheumatic heart disease.
How similar studies have performed: Other studies have shown positive outcomes with self-management education for chronic diseases, suggesting this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Inclusion criteria * Patients aged 15 years and above with verified diagnosis through echocardiography imaging. * Patients diagnosed as rheumatic heart disease for at least 6 months by a cardiologist. New York Heart Association (NYHA) function Class II/III. * Participants who possess the ability to effectively communicate, comprehend the study objectives, and * Provided consent to participate in the research. Exclusion Criteria: * Patients under serious medical conditions, * The existence of chronic illnesses like chronic obstructive pulmonary disease or asthma, diabetes, chronic kidney failure, stroke, or advanced-stage cancer.
Where this trial is running
Jimma, Oromi
- Jimma university — Jimma, Oromi, Ethiopia (RECRUITING)
Study contacts
- Study coordinator: Hiwot Berhanu Hiwot Berhanu (Assistant professor ), Masters of science (MSC)
- Email: hiwed2010@gmail.com
- Phone: +251(0)917324642
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Rheumatic Fever, Rheumatic Diseases